<DOC>
	<DOCNO>NCT01729182</DOCNO>
	<brief_summary>The purpose investigation collect follow data patient give Nexium capsule ( Nexium ) long term usual-post-marketing therapy prevention recurrence gastric ulcer duodenal ulcer Low dose Aspirin ( LDA ) .</brief_summary>
	<brief_title>Nexium Capsules LDA Specific Clinical Experience Investigation</brief_title>
	<detailed_description>Nexium capsule Specific Clinical Experience Investigation long-term use concern prevention recurrence gastric ulcer duodenal ulcer Low dose Aspirin ( LDA ) .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients gastric ulcer/duodenal ulcer Nexium start ( Active phase ( A1 , A2 ) heal phase ( H1 , H2 ) SakitaMiwa classification endoscopy ) . Patients give Nexium suppression recurrence gastric ulcer/duodenal ulcer .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Low dose Aspirin ( LDA )</keyword>
	<keyword>Gastric ulcer duodenal ulcer</keyword>
	<keyword>Nexium</keyword>
</DOC>